What one share of Pulse Biosciences holds
We are a novel ablation company committed to health innovation using our patented Nano-pulse Stimulation (“NPS”) technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to nonthermally clear or kill targeted cells.
Pulse Biosciences’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.02 |
|---|---|
| Profit | −$1.18 |
| Capex (buildings and equipment) | $0.00 |
| Free cash flow | −$0.90 |
| Cash and investments | $1.44 |
| Book value | $1.41 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2015 | — | −$0.37 | $0.01 | −$0.45 | — | $1.81 |
| 2016 | — | −$0.86 | $0.01 | −$0.74 | — | $1.90 |
| 2017 | — | −$1.73 | $0.17 | −$0.92 | — | $2.73 |
| 2018 | — | −$2.20 | $0.02 | −$1.42 | — | $3.22 |
| 2019 | — | −$2.26 | $0.03 | −$1.68 | — | $1.48 |
| 2020 | $0.00 | −$2.14 | $0.02 | −$1.54 | — | $0.90 |
| 2021 | $0.05 | −$2.28 | $0.02 | −$1.95 | — | $1.20 |
| 2022 | $0.02 | −$1.72 | $0.01 | −$1.40 | — | −$0.06 |
| 2023 | $0.00 | −$0.85 | $0.00 | −$0.67 | — | $0.80 |
| 2024 | $0.00 | −$0.92 | $0.00 | −$0.62 | — | $1.74 |
| 2025 | $0.01 | −$1.08 | $0.00 | −$0.81 | — | $1.19 |
Common questions about Pulse Biosciences
How much does one share of Pulse Biosciences earn?
Over the last 12 months, Pulse Biosciences lost $1.18 for each share on $0.02 of sales.
Does Pulse Biosciences pay a dividend?
Pulse Biosciences didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Pulse Biosciences’s book value per share?
Pulse Biosciences’s book value is $1.41 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Pulse Biosciences have?
Each share of Pulse Biosciences has $1.44 of cash and investments, as of June 30, 2026.
What is Pulse Biosciences’s free cash flow per share?
−$0.90 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Pulse Biosciences bought back shares?
Pulse Biosciences’s share count rose about 791% from 2015 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.